Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients

Ar, Muhlis Cem; Balkan, Can; Kavakli, Kaan

Ar, Muhlis Cem; Balkan, Can; Kavakli, Kaan.

Afiliación

Ar MC; Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
Balkan C; Ege University Faculty of Medicine, Department of Pediatrics, Division of Hemato-Oncology, Izmir, Turkey
Kavakli K; Ege University Faculty of Medicine, Department of Pediatrics, Division of Hemato-Oncology, Izmir, Turkey

Turk J Haematol ; 36(3): 141-154, 2019 08 02.

Article en En | MEDLINE | ID: mdl-31088040

Asunto(s)

Factores de Coagulación Sanguínea/uso terapéutico; Hemofilia A/terapia; Factores de Coagulación Sanguínea/farmacología; Semivida; Calidad de Vida

Palabras clave

Hemophilia; Factor replacement therapy; Extended half-life products; Laboratory assays; Pharmacokinetics; Quality of life

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Coagulación Sanguínea / Hemofilia A Idioma: En Revista: Turk J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google